Bahareh Khalili

Title: Innovations of Bahareh Khalili in Pharmaceutical Patents

Introduction

Bahareh Khalili is a prominent inventor based in Mississauga, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline forms of various compounds. With a total of 10 patents to her name, Khalili's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Khalili's latest patents include innovative crystalline forms of Acalabrutinib. The present invention provides several specific crystalline forms, including Acalabrutinib Form APO-I, a co-crystal of Acalabrutinib and urea; APO-II, a co-crystal of Acalabrutinib and nicotinamide; APO-III, a co-crystal of Acalabrutinib and L-sorbitol; APO-IV, a crystalline form of Acalabrutinib; and APO-V, a co-crystal of Acalabrutinib and urea. Additionally, she has developed novel crystalline forms of Ponatinib hydrochloride, which include Ponatinib hydrochloride Form APO-I, APO-III, and APO-IV, each obtained from acetonitrile/formic acid solutions. Form APO-V is also provided, which is obtained from concentrated hydrochloric acid.

Career Highlights

Khalili works at Apotex Inc., a leading pharmaceutical company known for its commitment to innovation and quality. Her work at Apotex has allowed her to focus on the development of new pharmaceutical formulations that can enhance the efficacy and safety of treatments.

Collaborations

Some of her notable coworkers include Fabio E S Souza and Annyt Bhattacharyya, who contribute to the collaborative environment that fosters innovation at Apotex.

Conclusion

Bahareh Khalili's contributions to the field of pharmaceuticals through her patents on crystalline forms of Acalabrutinib and Ponatinib hydrochloride highlight her role as a key innovator in the industry. Her work continues to pave the way for advancements in medical treatments.